Growth in this Sugar Excipients Market can be attributed to factors such as increasing use of co-processed excipients, rapid growth in the generics Market due to the patent expiration of many blockbuster drugs and increasing development of orally disintegrating tablets (ODTs).
The Sugar Excipients Market is expected to witness significant growth in the coming years due to the increasing use of co-processed excipients, rapid growth in the generics Market due to the patent expiration of many blockbuster drugs and increasing development of orally disintegrating tablets (ODTs). Increased regulatory requirements leading to a shortage of FDA-approved manufacturing sites is expected to hinder the growth of this Market.
Sugar Excipients Market segmentation:
· based on product
· based on the type
· based on functionality
· based on the formulation
· based on regions.
The Major Players Operating in the Sugar Excipients Market:
The global Sugar Excipients Market is dominated by Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), and Ashland Inc. (U.S.), which together accounted for ~40% to 45% of the Global Market. The rest of the Market is fragmented in nature with the presence of many local and regional players.
Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), and Ashland Inc. (U.S.), held the major share of the Sugar Excipients Market, and are expected to dominate the Market during the forecast period. Other major players in this Market are Associated British Foods Plc (U.K.), Cargill, Inc. (U.S.), Colorcon, Inc. (U.S.), FMC Corporation (U.S.), MEGGLE AG (Germany), and The Lubrizol Corporation (U.S.).
Geographical Detailed Analysis for Sugar Excipients Market:
Europe is the largest regional segment for the global Sugar Excipients Market.
The large share of this regional segment can be attributed to increasing investments in drug development, increasing the production of generic drugs, and favorable government initiatives in the region.
The Sugar Excipients Market in the Asia-Pacific region is expected to register the highest CAGR owing to the significant growth in the regional healthcare Market as well as the pharmaceutical industry, growing scientific base and capability, and favorable government policies, and low-cost manufacturing advantage in this region.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly